NEVRO CORP Insider Trading for August 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEVRO CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEVRO CORP for August 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 24 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 100.00 | 2,000 | 200,000 | 1,690 | 3.7 K to 1.7 K (-54.20 %) |
Aug 24 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 100.00 | 1,000 | 100,000 | 5,961 | 7 K to 6 K (-14.37 %) |
Aug 24 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 99.00 | 3,334 | 330,066 | 4,255 | 7.6 K to 4.3 K (-43.93 %) |
Aug 24 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 99.00 | 3,334 | 330,066 | 72,554 | 75.9 K to 72.6 K (-4.39 %) |
Aug 24 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 99.00 | 6,666 | 659,934 | 485,920 | 492.6 K to 485.9 K (-1.35 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 99.89 | 79 | 7,891 | 25,797 | 25.9 K to 25.8 K (-0.31 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.58 | 137 | 13,505 | 25,876 | 26 K to 25.9 K (-0.53 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 99.89 | 3,567 | 356,305 | 1,168,321 | 1.2 M to 1.2 M (-0.30 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.58 | 6,217 | 612,841 | 1,171,888 | 1.2 M to 1.2 M (-0.53 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.30 | 370 | 36,372 | 26,013 | 26.4 K to 26 K (-1.40 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.86 | 1,034 | 101,192 | 26,383 | 27.4 K to 26.4 K (-3.77 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.30 | 16,753 | 1,646,874 | 1,178,105 | 1.2 M to 1.2 M (-1.40 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.86 | 46,843 | 4,584,276 | 1,194,858 | 1.2 M to 1.2 M (-3.77 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.14 | 50 | 4,907 | 27,417 | 27.5 K to 27.4 K (-0.18 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.53 | 1,459 | 142,300 | 27,467 | 28.9 K to 27.5 K (-5.04 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.88 | 216 | 20,926 | 28,926 | 29.1 K to 28.9 K (-0.74 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.14 | 2,250 | 220,807 | 1,241,701 | 1.2 M to 1.2 M (-0.18 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.53 | 66,066 | 6,443,576 | 1,243,951 | 1.3 M to 1.2 M (-5.04 %) |
Aug 22 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.88 | 9,799 | 949,341 | 1,310,017 | 1.3 M to 1.3 M (-0.74 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.16 | 661 | 63,559 | 29,142 | 29.8 K to 29.1 K (-2.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.16 | 29,953 | 2,880,143 | 1,319,816 | 1.3 M to 1.3 M (-2.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.06 | 73 | 7,086 | 29,803 | 29.9 K to 29.8 K (-0.24 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.02 | 457 | 43,880 | 29,876 | 30.3 K to 29.9 K (-1.51 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.06 | 3,327 | 322,932 | 1,349,769 | 1.4 M to 1.3 M (-0.25 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 96.02 | 20,689 | 1,986,494 | 1,353,096 | 1.4 M to 1.4 M (-1.51 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.66 | 121 | 11,938 | 30,333 | 30.5 K to 30.3 K (-0.40 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.90 | 2,039 | 199,617 | 30,454 | 32.5 K to 30.5 K (-6.28 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 98.66 | 5,487 | 541,339 | 1,373,785 | 1.4 M to 1.4 M (-0.40 %) |
Aug 17 2016 | NVRO | NEVRO CORP | JAEGER WILFRED E | Director | Sell | S | 97.90 | 92,353 | 9,041,331 | 1,379,272 | 1.5 M to 1.4 M (-6.28 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 18.00 | 5,047 | 90,846 | 46,852 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 2,374 | 8,546 | 42,430 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Option Exercise | M | 3.60 | 79 | 284 | 62,861 | |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 98.85 | 100 | 9,885 | 30,000 | 30.1 K to 30 K (-0.33 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 98.09 | 3,194 | 313,286 | 30,100 | 33.3 K to 30.1 K (-9.59 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Sell | S | 97.39 | 4,206 | 409,620 | 33,294 | 37.5 K to 33.3 K (-11.22 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 18.00 | 5,047 | 90,846 | 37,500 | 32.5 K to 37.5 K (+15.55 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 2,374 | 8,546 | 32,453 | 30.1 K to 32.5 K (+7.89 %) |
Aug 17 2016 | NVRO | NEVRO CORP | Galligan Andrew H | Chief Financial Off ... | Buy | M | 3.60 | 79 | 284 | 30,079 | 30 K to 30.1 K (+0.26 %) |
Aug 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 95.00 | 1,500 | 142,500 | 3,690 | 5.2 K to 3.7 K (-28.90 %) |
Aug 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 95.00 | 1,500 | 142,500 | 3,690 | 5.2 K to 3.7 K (-28.90 %) |
Aug 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 95.00 | 1,000 | 95,000 | 6,961 | 8 K to 7 K (-12.56 %) |
Aug 12 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 95.00 | 1,000 | 95,000 | 6,961 | 8 K to 7 K (-12.56 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 94.00 | 3,334 | 313,396 | 7,589 | 10.9 K to 7.6 K (-30.52 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 89.00 | 3,333 | 296,637 | 10,923 | 14.3 K to 10.9 K (-23.38 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 94.00 | 3,334 | 313,396 | 75,888 | 79.2 K to 75.9 K (-4.21 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 89.00 | 3,333 | 296,637 | 79,222 | 82.6 K to 79.2 K (-4.04 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 94.00 | 6,666 | 626,604 | 492,586 | 499.3 K to 492.6 K (-1.34 %) |
Aug 11 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 89.00 | 6,667 | 593,363 | 499,252 | 505.9 K to 499.3 K (-1.32 %) |
Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 86,108 | |
Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 82.06 | 1,500 | 123,094 | 37,963 | 39.5 K to 38 K (-3.80 %) |
Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
Aug 02 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 84.00 | 3,333 | 279,972 | 14,256 | 17.6 K to 14.3 K (-18.95 %) |
Aug 02 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 84.00 | 3,333 | 279,972 | 82,555 | 85.9 K to 82.6 K (-3.88 %) |
Aug 02 2016 | NVRO | NEVRO CORP | DEMANE MICHAEL F | Director | Sell | S | 84.00 | 6,667 | 560,028 | 505,919 | 512.6 K to 505.9 K (-1.30 %) |
Aug 02 2016 | NVRO | NEVRO CORP | Alleavitch Doug | VP, Quality | Sell | S | 85.00 | 1,000 | 85,000 | 7,961 | 9 K to 8 K (-11.16 %) |